CLAIM #23038 · EMR (EMR) · 2026Q2 earnings call · May 5, 2026 · due Sep 30, 2026
“Safety and Productivity is expected to grow 1% in Q3 and 2% for the full year.”
Michael Baughman · CFO
How to check this claim
Look at: Safety and Productivity segment net sales growth rate (year-over-year), Q3 fiscal 2026 and full fiscal year 2026
It came true if: Q3 growth approximately 1% (0.5%-1.5%) and full-year growth approximately 2% (1.5%-2.5%)
Where: Emerson Electric Co. segment reporting in quarterly earnings release / 10-Q and 10-K (Safety and Productivity segment)
In context
“owth verticals in this business and strength in the U.S. Test and Measurement is planned to grow mid-teens in Q3 and low teens for the full year, up from our prior expectations of high single-digit growth in 2026. The Control Systems and Software segment is expected to grow mid-single digits in Q3 and low single digits for the full year. We continue to see robust adoption of our software and still expect ACV growth of 10% plus in 2026. Intelligent Devices is projected to grow 4% in Q3, and we are lowering our full-year expectations to approximately 2% driven by the conflict in the Middle East. Second-half growth in Intelligent Devices is supported by backlog phasing and the timing of product shipments, with strength in the U.S. and growth verticals offsetting a slower-than-expected China. Safety and Productivity is expected to grow 1% in Q3 and 2% for the full year. The North America market continues to recover; we are seeing sustained strength in electric utilities. However, automotive and European markets remain weak. Overall, Emerson Electric Co. expects to grow approximately 5% in Q3 and 3% for the full year. Excluding the impact of software contract renewals, Emerson Electric Co.’s growth rate is expected to be 4% for the full year. Please turn to Slide 12 for details on our Q3 and full-year 2026 guidance. Before going through the details, I would like to highlight a few important assumptions embedded in our guidance. Our guidance considers a gradual resumption of activity in the Middle East and assumes the impact of the conflict remains in the region. Additionally, we expect a net neutral impact from the removal of IEBA tariffs, as this benefit”
Verify independently
SEC filings for EMR ↗ · Claim quote is verbatim from the 2026Q2 earnings call.